For symptoms of scalp psoriasis, home treatments like olive oil, oatmeal, and apple cider vinegar may provide relief and make ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

More than 50% of patients with psoriasis are eligible for systemic treatment, and nearly 90% would switch to an effective oral therapy with a favorable safety profile.

The use of interleukin (IL)-23 inhibitors plays an important role in treating patients with psoriasis, as well as in treating ...

Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

Psoriasis can feel like an uninvited guest that shows up on your skin and refuses to leave. Those red, scaly patches—often ...

Eczema and psoriasis come with similar symptoms and therefore can be easy to confuse. Here's how to differentiate the two.

On World Psoriasis Day 2025, know how stress may spark flare-ups of Psoriasis, why the link matters, and what you can do to ...

In March 2025, SFA Therapeutics announced that two head-to-head preclinical studies of its oral psoriasis therapy candidate, ...

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.